A 50-Gene Predictor of Recurrence as a Guide to Therapy in Early-Stage Colon Cancer.
收藏官方服务：
资源简介：
A 50-Gene Predictor of Recurrence as a Guide to Therapy in Early-Stage Colon Cancer.
应用场景：
创建时间：
2010-05-15
相关数据集
High Accordance in Prognosis Prediction of Colorectal Cancer across Independent Datasets by Multi-Gene Module Expression Profiles
A considerable portion of patients with colorectal cancer have a high risk of disease recurrence after surgery. These patients can be identified by analyzing the expression profiles of signature genes
NIAID Data Ecosystem60
The diagnostic accuracy of a single CEA blood test in detecting colorectal cancer recurrence: Results from the FACS trial
Objective To evaluate the diagnostic accuracy of a single CEA (carcinoembryonic antigen) blood test in detecting colorectal cancer recurrence. Background Patients who have undergone curative resection
NIAID Data Ecosystem50
DataSheet_2_Clinical Significance and Inflammatory Landscape of aNovel Recurrence-Associated Immune Signature in Stage II/III Colorectal Cancer.docx
BackgroundA considerable number of patients with stage II/III colorectal cancer (CRC) will relapse within 5 years after surgery, which is a leading cause of death in early-stage CRC. The current TNM s
NIAID Data Ecosystem40
Monitoring circulating tumor DNA by using panel-specific sequencing to predict recurrence in colorectal cancer after surgical resection. human feces metagenome
BACKGROUND AND AIMS: Irritable bowel syndrome (IBS) is a disorder of gut-brain interaction, including dysregulation of the hypothalamic-pituitary-adrenal axis with salivary cortisol changes. However,
NIAID Data Ecosystem50
TABLE 2 from Development and Validation of a 15-gene Expression Signature with Superior Prognostic Ability in Stage II Colorectal Cancer
Multivariate Cox proportional hazards models for estimating the contribution of indicated variables to predict recurrence in indicated patient cohorts
NIAID Data Ecosystem50
